{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:49:48Z","timestamp":1770896988317,"version":"3.50.1"},"reference-count":52,"publisher":"American Association for Laboratory Animal Science","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>Significant weight loss in mice (<jats:italic>Mus musculus<\/jats:italic>) is a welfare concern and can alter physiology and behavior in ways that may confound research aims. In this study, factorial design was used to investigate the effect of enterally administered capromorelin on changes in mouse body weight overall and with various research-related interventions, such as administration of analgesics, anesthesia, or surgery. BALB\/c mice (<jats:italic>n\u2009<\/jats:italic>=<jats:italic>\u2009<\/jats:italic>61 [27 males\/34 females] for analysis) were randomized into 8 intervention-treatment groups with 2 treatment allocations: capromorelin (10 mg\/kg) or control, and 4 intervention allocations: no intervention; buprenorphine extended-release (XR) alone; buprenorphine XR, meloxicam, and anesthesia; or surgery under anesthesia with buprenorphine XR, meloxicam, and bupivacaine administered. Mice were habituated to handling, weighing, and voluntary consumption of condensed milk, which was used as the control solution and later a vehicle for capromorelin delivery, for 5 d (days 0 to 4). Then, mice received their interventions followed by 3 days of daily treatment or control administration (days 7 to 9). Body weights were measured daily (days 8 to 11 and day 14) to compare with baseline weights (days 0 to 4 and day 7) and evaluate for treatment and intervention effects on body weight. The interventions resulted in a decrease in group body weights 3 and 4 d after the interventions were conducted. Overall, body weights increased more in mice given capromorelin compared with control, and mice treated with capromorelin returned to, or exceeded, baseline weights faster. The weight loss was mitigated by capromorelin administration in all interventions except for the buprenorphine XR-only group. It is recommended to clinically consider enterally administered capromorelin to mitigate research-induced weight loss in mice.<\/jats:p>","DOI":"10.30802\/aalas-cm-24-031","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T01:05:35Z","timestamp":1721351135000},"page":"327-335","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the Effect of Enterally Administered Capromorelin on Body Weight in Mice (Mus musculus)"],"prefix":"10.30802","volume":"74","author":[{"given":"Elizabeth M","family":"Punger","sequence":"first","affiliation":[{"name":"Veterinary Services Branch, Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L W","family":"Norris","sequence":"additional","affiliation":[{"name":"Research Support Branch, Regulated Research Administration Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C","family":"Stevens","sequence":"additional","affiliation":[{"name":"Veterinary Services Branch, Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kacee H","family":"Santos","sequence":"additional","affiliation":[{"name":"Veterinary Services Branch, Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C","family":"Christy","sequence":"additional","affiliation":[{"name":"Veterinary Services Branch, Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"Neuroscience","first-page":"554","article-title":"Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake","volume":"167","author":"Anghel A","year":"2010","unstructured":"Anghel A, Jamieson CA, Ren X, Young J, Porche R, Ozigbo E, Ghods DE, et al. 2010. Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake. Neuroscience 167:554\u2013566."},{"key":"bib2","series-title":"J Am Assoc Lab Anim Sci","first-page":"617","article-title":"Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: Effects on body weight, locomotor activity, and hemodynamic parameters","volume":"49","author":"Bourque SL","year":"2010","unstructured":"Bourque SL, Adams MA, Nakatsu K, Winterborn A. 2010. Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: Effects on body weight, locomotor activity, and hemodynamic parameters. J Am Assoc Lab Anim Sci 49:617\u2013622."},{"key":"bib3","series-title":"Nephrol Dial Transplant","first-page":"523","article-title":"Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: A randomized blinded study","volume":"33","author":"Campbell GA","year":"2018","unstructured":"Campbell GA, Patrie JT, Gaylinn BD, Thorner MO, Bolton WK. 2018. Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: A randomized blinded study. Nephrol Dial Transplant 33:523\u2013530."},{"key":"bib4","series-title":"J Am Assoc Lab Anim Sci","first-page":"268","article-title":"Evaluating the safety and efficacy of capromorelin in rhesus macaques (Macaca mulatta)","volume":"63","author":"Campellone GA","year":"2014","unstructured":"Campellone GA, Easley KA, Jenkins JB, Jean SM. 2014. Evaluating the safety and efficacy of capromorelin in rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci 63:268\u2013278."},{"key":"bib5","series-title":"Sci Rep","first-page":"493","article-title":"Estimating mouse and rat use in American laboratories by extrapolation from Animal Welfare Act-regulated species","volume":"11","author":"Carbone L","year":"2021","unstructured":"Carbone L. 2021. Estimating mouse and rat use in American laboratories by extrapolation from Animal Welfare Act-regulated species. Sci Rep 11:493."},{"key":"bib6","series-title":"Bioorg Med Chem","first-page":"581","article-title":"Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin","volume":"11","author":"Carpino PA","year":"2003","unstructured":"Carpino PA, Lefker BA, Toler SM, Pan LC, Hadcock JR, Cook ER, DiBrino JN, et al. 2003. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorg Med Chem 11:581\u2013590."},{"key":"bib7","series-title":"ILAR J","first-page":"62","article-title":"Recognizing pain and distress in laboratory animals","volume":"41","author":"Carstens E","year":"2000","unstructured":"Carstens E, Moberg GP. 2000. Recognizing pain and distress in laboratory animals. ILAR J 41:62\u201371."},{"key":"bib8","series-title":"Front Neuroendocrinol","first-page":"44","article-title":"Ghrelin in the regulation of body weight and metabolism","volume":"31","author":"Casta\u00f1eda TR","year":"2010","unstructured":"Casta\u00f1eda TR, Tong J, Datta R, Culler M, Tsch\u00f6p MH. 2010. Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 31:44\u201360."},{"key":"bib9","series-title":"Poult Sci","first-page":"101204","article-title":"Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus)","volume":"100","author":"Ceron-Romero N","year":"2021","unstructured":"Ceron-Romero N, Taofeek N, Thomas A, Vroonland E, Sanmartin K, Verghese M, Heinen E, Vizcarra JA. 2021. Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus). Poult Sci 100:101204."},{"key":"bib10","series-title":"J Pharmacol Exp Ther","first-page":"1178","article-title":"Enhanced gastrointestinal motility with orally active ghrelin receptor agonists","volume":"329","author":"Charoenthongtrakul S","year":"2009","unstructured":"Charoenthongtrakul S, Giuliana D, Longo KA, Govek EK, Nolan A, Gagne S, Morgan K, et al. 2009. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther 329:1178\u20131186."},{"key":"bib11","series-title":"J Am Assoc Lab Anim Sci","first-page":"495","article-title":"Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White Rabbits (Oryctolagus cuniculus)","volume":"61","author":"Draper JM","year":"2022","unstructured":"Draper JM, Savson DJ, Lavin ES, Feldman ER, Singh B, Martin-Flores M, Daugherity EK. 2022. Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White Rabbits (Oryctolagus cuniculus). J Am Assoc Lab Anim Sci 61:495\u2013505."},{"key":"bib12","series-title":"Addict Biol","first-page":"304","article-title":"Ghrelin increases intake of rewarding food in rodents","volume":"15","author":"Egecioglu E","year":"2010","unstructured":"Egecioglu E, Jerlhag E, Salom\u00e9 N, Skibicka KP, Haage D, Bohlooly YM, Andersson D, et al. 2010. Ghrelin increases intake of rewarding food in rodents. Addict Biol 15:304\u2013311."},{"key":"bib13","article-title":"Elanco","year":"2020","unstructured":"Elura. [Package insert]. 2020. Elanco. [Cited 21 February 2024]. Available at: https:\/\/www.elancolabels.com\/us\/elura."},{"key":"bib14","article-title":"Elanco","year":"2020","unstructured":"Entyce. [Package insert]. 2020. Elanco. [Cited 21 February 2024]. Available at: https:\/\/www.elancolabels.com\/us\/entyce-promotional-label."},{"key":"bib15","article-title":"Fidelis animal health","year":"2018","unstructured":"Ethiqa XR. [Package insert]. 2018. Fidelis animal health. [Cited 21 February 2024]. Available at: https:\/\/www.fda.gov\/media\/87139\/download."},{"key":"bib16","article-title":"Fidelis animal health","year":"2024","unstructured":"Ethiqa XR Frequently Asked Questions. [Internet]. 2024. Fidelis animal health. [Cited 21 February 2024]. Available at: https:\/\/ethiqaxr.com\/faqs\/."},{"key":"bib17","series-title":"Elife","first-page":"e70271","article-title":"Assessing the effects of stress on feeding behaviors in laboratory mice","volume":"11","author":"Francois M","year":"2022","unstructured":"Francois M, Canal Delgado I, Shargorodsky N, Leu CS, Zeltser L. 2022. Assessing the effects of stress on feeding behaviors in laboratory mice. Elife 11:e70271."},{"key":"bib18","series-title":"Ferrets, rabbits, and rodents","first-page":"345","article-title":"Rats and mice","author":"Frohlich J","year":"2020","unstructured":"Frohlich J. 2020. Rats and mice, p 345\u2013367. In: Quesenberry KE, Orcutt CJ, Mans C, Carpenter JW, editors. Ferrets, rabbits, and rodents, 4th ed. Philadelphia (PA): W.B. Saunders."},{"key":"bib19","series-title":"Vet Sci","first-page":"589","article-title":"Effects of a multimodal approach using buprenorphine with\/without meloxicam on food intake, body weight, nest consolidating behavior, burrowing behavior, and gastrointestinal tissues in postoperative male mice","volume":"9","author":"Furumoto K","year":"2022","unstructured":"Furumoto K, Sasaki Y, Nohara M, Takenaka N, Maeta N, Kanda T. 2022. Effects of a multimodal approach using buprenorphine with\/without meloxicam on food intake, body weight, nest consolidating behavior, burrowing behavior, and gastrointestinal tissues in postoperative male mice. Vet Sci 9:589."},{"key":"bib20","series-title":"J Am Assoc Lab Anim Sci","first-page":"87","article-title":"Efficacy of supplemental diet gels for preventing postoperative weight loss in mice (Mus musculus)","volume":"62","author":"Gates KV","year":"2023","unstructured":"Gates KV, Alamaw E, Jampachaisri K, Huss MK, Pacharinsak C. 2023. Efficacy of supplemental diet gels for preventing postoperative weight loss in mice (Mus musculus). J Am Assoc Lab Anim Sci 62:87\u201391."},{"key":"bib21","series-title":"Principles of animal research for graduate and undergraduate students.","first-page":"117","article-title":"Commonly used animal models","author":"Hickman DL","year":"2017","unstructured":"Hickman DL, Johnson J, Vemulapalli TH, Crisler JR, Shepherd R. 2017. Commonly used animal models, p 117\u2013175. In: Suckow MA, Stewart KL, eds. Principles of animal research for graduate and undergraduate students. New York (NY): Academic Press."},{"key":"bib22","series-title":"PLoS One","first-page":"e0179588","article-title":"Severity classification of repeated isoflurane anesthesia in C57BL\/6JRj mice-assessing the degree of distress","volume":"12","author":"Hohlbaum K","year":"2017","unstructured":"Hohlbaum K, Bert B, Dietze S, Palme R, Fink H, Th\u00f6ne-Reineke C. 2017. Severity classification of repeated isoflurane anesthesia in C57BL\/6JRj mice-assessing the degree of distress. PLoS One 12:e0179588."},{"key":"bib23","series-title":"Guide for the care and use of laboratory animals","year":"2011","unstructured":"Institute for Laboratory Animal Research. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press."},{"key":"bib24","series-title":"Lab Anim","first-page":"225","article-title":"Fasting of mice: A review","volume":"47","author":"Jensen TL","year":"2013","unstructured":"Jensen TL, Kiersgaard MK, S\u00f8rensen DB, Mikkelsen LF. 2013. Fasting of mice: A review. Lab Anim 47:225\u2013240."},{"key":"bib25","series-title":"J Am Stat Assoc","first-page":"457","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan EL","year":"1958","unstructured":"Kaplan EL, Meier P. 1958. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481."},{"key":"bib26","series-title":"Biometrics","first-page":"983","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward MG","year":"1997","unstructured":"Kenward MG, Roger JH. 1997. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983\u2013997."},{"key":"bib27","series-title":"J Am Assoc Lab Anim Sci","first-page":"74","article-title":"High-dose meloxicam provides improved analgesia in female CD1 mice: A pharmacokinetic and efficacy study","volume":"62","author":"Kim J","year":"2023","unstructured":"Kim J, Cannon BA, Freeman LE, Tan S, Knych HK, Kendall LV. 2023. High-dose meloxicam provides improved analgesia in female CD1 mice: A pharmacokinetic and efficacy study. J Am Assoc Lab Anim Sci 62:74\u201380."},{"key":"bib28","series-title":"Gut","first-page":"1078","article-title":"Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro","volume":"54","author":"Kitazawa T","year":"2005","unstructured":"Kitazawa T, De Smet B, Verbeke K, Depoortere I, Peeters TL. 2005. Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 54:1078\u20131084."},{"key":"bib29","series-title":"Endocrinology","first-page":"155","article-title":"Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers","volume":"143","author":"Lawrence CB","year":"2002","unstructured":"Lawrence CB, Snape AC, Baudoin FM, Luckman SM. 2002. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143:155\u2013162."},{"key":"bib30","series-title":"Int J Obes (Lond)","first-page":"S98","article-title":"Molecular physiology of weight regulation in mice and humans","volume":"32 Suppl 7","author":"Leibel RL","year":"2008","unstructured":"Leibel RL. 2008. Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond) 32 Suppl 7:S98\u2013108."},{"key":"bib31","series-title":"Drug Discov Today","first-page":"276","article-title":"Physiological, pathological and potential therapeutic roles of ghrelin","volume":"12","author":"Leite-Moreira AF","year":"2007","unstructured":"Leite-Moreira AF, Soares JB. 2007. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 12:276\u2013288."},{"key":"bib32","series-title":"J Am Assoc Lab Anim Sci","first-page":"42","article-title":"Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice","volume":"51","author":"Matsumiya LC","year":"2012","unstructured":"Matsumiya LC, Sorge RE, Sotocinal SG, Tabaka JM, Wieskopf JS, Zaloum A, King OD, Mogil JS. 2012. Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice. J Am Assoc Lab Anim Sci 51:42\u201349."},{"key":"bib33","series-title":"J Am Assoc Lab Anim Sci","first-page":"186","article-title":"Using cageside measures to evaluate analgesic efficacy in mice (Mus musculus) after surgery","volume":"57","author":"Oliver VL","year":"2018","unstructured":"Oliver VL, Thurston SE, Lofgren JL. 2018. Using cageside measures to evaluate analgesic efficacy in mice (Mus musculus) after surgery. J Am Assoc Lab Anim Sci 57:186\u2013201."},{"key":"bib34","series-title":"Evol Med Public Health","first-page":"170","article-title":"Mouse models of human disease: An evolutionary perspective","volume":"2016","author":"Perlman RL","year":"2016","unstructured":"Perlman RL. 2016. Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 2016:170\u2013176."},{"key":"bib35","series-title":"J R Stat Soc Ser A","first-page":"185","article-title":"Asymptotically efficient rank invariant test procedures","volume":"135","author":"Peto R","year":"1972","unstructured":"Peto R, Peto J. 1972. Asymptotically efficient rank invariant test procedures. J R Stat Soc Ser A 135:185\u2013207."},{"key":"bib36","series-title":"Neurogastroenterol Motil","first-page":"610","article-title":"A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation","volume":"27","author":"Pustovit RV","year":"2015","unstructured":"Pustovit RV, Furness JB, Rivera LR. 2015. A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation. Neurogastroenterol Motil 27:610\u2013617."},{"key":"bib37","series-title":"Vet Res Commun","first-page":"1","article-title":"Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine","volume":"48","author":"Rathore M","year":"2024","unstructured":"Rathore M, Das N, Ghosh N, Guha R. 2024. Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine. Vet Res Commun 48:1\u201310."},{"key":"bib38","series-title":"Vet Med Sci","first-page":"3","article-title":"Capromorelin: A ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs","volume":"4","author":"Rhodes L","year":"2018","unstructured":"Rhodes L, Zollers B, Wofford JA, Heinen E. 2018. Capromorelin: A ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Vet Med Sci 4:3\u201316."},{"key":"bib39","series-title":"J Am Assoc Lab Anim Sci","first-page":"468","article-title":"Pharmacokinetics of sustained-release and extended-release buprenorphine in mice after surgical catheterization","volume":"61","author":"Saenz M","year":"2022","unstructured":"Saenz M, Bloom-Saldana EA, Synold T, Ermel RW, Fueger PT, Finlay JB. 2022. Pharmacokinetics of sustained-release and extended-release buprenorphine in mice after surgical catheterization. J Am Assoc Lab Anim Sci 61:468\u2013474."},{"key":"bib40","series-title":"Biometrika","first-page":"591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro SS","year":"1965","unstructured":"Shapiro SS, Wilk MB. 1965. An analysis of variance test for normality (complete samples). Biometrika 52:591\u2013611."},{"key":"bib41","series-title":"Endocr Rev","first-page":"346","article-title":"Development of growth hormone secretagogues","volume":"26","author":"Smith RG","year":"2005","unstructured":"Smith RG. 2005. Development of growth hormone secretagogues. Endocr Rev 26:346\u2013360."},{"key":"bib42","series-title":"Gut","first-page":"327","article-title":"Influence of ghrelin on interdigestive gastrointestinal motility in humans","volume":"55","author":"Tack J","year":"2006","unstructured":"Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T. 2006. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55:327\u2013333."},{"key":"bib43","series-title":"Lab Anim","first-page":"99","article-title":"Defining body-weight reduction as a humane endpoint: A critical appraisal","volume":"54","author":"Talbot SR","year":"2020","unstructured":"Talbot SR, Biernot S, Bleich A, van Dijk RM, Ernst L, H\u00e4ger C, Helgers SOA, et al. 2020. Defining body-weight reduction as a humane endpoint: A critical appraisal. Lab Anim 54:99\u2013110."},{"key":"bib44","series-title":"Nature","first-page":"908","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tsch\u00f6p M","year":"2000","unstructured":"Tsch\u00f6p M, Smiley DL, Heiman ML. 2000. Ghrelin induces adiposity in rodents. Nature 407:908\u2013913."},{"key":"bib45","series-title":"Nat Methods","first-page":"57","article-title":"A guide to analysis of mouse energy metabolism","volume":"9","author":"Tsch\u00f6p MH","year":"2011","unstructured":"Tsch\u00f6p MH, Speakman JR, Arch JR, Auwerx J, Br\u00fcning JC, Chan L, Eckel RH, et al. 2011. A guide to analysis of mouse energy metabolism. Nat Methods 9:57\u201363."},{"key":"bib46","series-title":"Comp Med","first-page":"451","article-title":"A review of pain assessment methods in laboratory rodents","volume":"69","author":"Turner PV","year":"2019","unstructured":"Turner PV, Pang DS, Lofgren JL. 2019. A review of pain assessment methods in laboratory rodents. Comp Med 69:451\u2013467."},{"key":"bib47","article-title":"New animal drug application 141-536 ELURA capromorelin oral solution","year":"2020","unstructured":"U.S. Food and Drug Administration. [Internet]. 2020. New animal drug application 141-536 ELURA capromorelin oral solution. [Cited 21 February 2024]. Available at: https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/9908."},{"key":"bib48","series-title":"J Clin Endocrinol Metab","first-page":"1198","article-title":"Effects of an oral growth hormone secretagogue in older adults","volume":"94","author":"White HK","year":"2009","unstructured":"White HK, Petrie CD, Landschulz W, MacLean D, Taylor A, Lyles K, Wei JY, Capromorelin Study Group, et al. 2009. Effects of an oral growth hormone secretagogue in older adults. J Clin Endocrinol Metab 94:1198\u20131206."},{"key":"bib49","series-title":"J Vet Pharmacol Ther","first-page":"324","article-title":"Evaluation of the safety of daily administration of capromorelin in cats","volume":"41","author":"Wofford JA","year":"2018","unstructured":"Wofford JA, Zollers B, Rhodes L, Bell M, Heinen E. 2018. Evaluation of the safety of daily administration of capromorelin in cats. J Vet Pharmacol Ther 41:324\u2013333."},{"key":"bib50","series-title":"Pain","first-page":"108","article-title":"Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone levels and behaviour in two strains of laboratory mouse","volume":"130","author":"Wright-Williams SL","year":"2007","unstructured":"Wright-Williams SL, Courade JP, Richardson CA, Roughan JV, Flecknell PA. 2007. Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone levels and behaviour in two strains of laboratory mouse. Pain 130:108\u2013118."},{"key":"bib51","series-title":"BMC Vet Res","first-page":"10","article-title":"Capromorelin oral solution (ENTYCE) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study","volume":"13","author":"Zollers B","year":"2017","unstructured":"Zollers B, Rhodes L, Heinen E. 2017. Capromorelin oral solution (ENTYCE) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. BMC Vet Res 13:10."},{"key":"bib52","series-title":"J Vet Intern Med","first-page":"1851","article-title":"A prospective, randomized, masked, placebo-controlled clinical study of capromorelin in dogs with reduced appetite","volume":"30","author":"Zollers B","year":"2016","unstructured":"Zollers B, Wofford JA, Heinen E, Huebner M, Rhodes L. 2016. A prospective, randomized, masked, placebo-controlled clinical study of capromorelin in dogs with reduced appetite. J Vet Intern Med 30:1851\u20131857."}],"container-title":["Comparative Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010023\/74\/5\/article-p327.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010023\/74\/5\/article-p327.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010023\/74\/5\/article-p327.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:31:33Z","timestamp":1734741093000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010023\/74\/5\/article-p327.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":52,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.30802\/aalas-cm-24-031","relation":{},"ISSN":["1532-0820"],"issn-type":[{"value":"1532-0820","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}